Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics

Takaaki Akaike,Tomoaki Ida,Fan-Yan Wei,Motohiro Nishida,Yoshito Kumagai,Md. Morshedul Alam,Hideshi Ihara,Tomohiro Sawa,Tetsuro Matsunaga,Shingo Kasamatsu,Akiyuki Nishimura,Masanobu Morita,Kazuhito Tomizawa,Akira Nishimura,Satoshi Watanabe,Kenji Inaba,Hiroshi Shima,Nobuhiro Tanuma,Minkyung Jung,Shigemoto Fujii,Yasuo Watanabe,Masaki Ohmuraya,Péter Nagy,Martin Feelisch,Jon M. Fukuto,Hozumi Motohashi
DOI: https://doi.org/10.1038/s41467-017-01311-y
IF: 16.6
2017-10-27
Nature Communications
Abstract:Cysteine hydropersulfide (CysSSH) occurs in abundant quantities in various organisms, yet little is known about its biosynthesis and physiological functions. Extensive persulfide formation is apparent in cysteine-containing proteins in Escherichia coli and mammalian cells and is believed to result from post-translational processes involving hydrogen sulfide-related chemistry. Here we demonstrate effective CysSSH synthesis from the substrate l-cysteine, a reaction catalyzed by prokaryotic and mammalian cysteinyl-tRNA synthetases (CARSs). Targeted disruption of the genes encoding mitochondrial CARSs in mice and human cells shows that CARSs have a crucial role in endogenous CysSSH production and suggests that these enzymes serve as the principal cysteine persulfide synthases in vivo. CARSs also catalyze co-translational cysteine polysulfidation and are involved in the regulation of mitochondrial biogenesis and bioenergetics. Investigating CARS-dependent persulfide production may thus clarify aberrant redox signaling in physiological and pathophysiological conditions, and suggest therapeutic targets based on oxidative stress and mitochondrial dysfunction.
multidisciplinary sciences
What problem does this paper attempt to address?